Nifty
Sensex
:
:
11600.20
39090.03
326.00 (2.89%)
1075.41 (2.83%)

Pharmaceuticals & Drugs

Rating :
61/99

BSE: 500288 | NSE: MOREPENLAB

23.15
23-Sep-2019
  • Open
  • High
  • Low
  • Previous Close
  •  19.55
  •  23.15
  •  19.50
  •  19.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3948950
  •  856.01
  •  26.90
  •  14.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 865.92
  • 25.43
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 845.65
  • N/A
  • 3.32

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 34.54%
  • 3.92%
  • 40.25%
  • FII
  • DII
  • Others
  • 0.58%
  • 13.39%
  • 7.32%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.75
  • 13.92
  • 8.88

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.23
  • 6.96
  • 1.93

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 68.25
  • 6.88

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 33.59
  • 45.99
  • 40.22

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.90
  • 4.22
  • 4.26

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.93
  • 16.82
  • 16.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
202.98
163.73
23.97%
218.72
0.00
0.00
212.16
0.00
0.00
173.94
0.00
0.00
Expenses
183.65
151.55
21.18%
196.97
0.00
0.00
195.32
0.00
0.00
157.18
0.00
0.00
EBITDA
19.33
12.18
58.70%
21.75
0.00
0.00
16.83
0.00
0.00
16.76
0.00
0.00
EBIDTM
9.52%
7.44%
9.94%
0.00%
7.93%
0.00%
9.64%
0.00%
Other Income
0.28
0.08
250.00%
1.03
0.00
0.00
2.43
0.00
0.00
0.13
0.00
0.00
Interest
0.43
0.44
-2.27%
0.93
0.00
0.00
0.43
0.00
0.00
0.32
0.00
0.00
Depreciation
11.50
9.16
25.55%
11.15
0.00
0.00
9.80
0.00
0.00
9.79
0.00
0.00
PBT
7.68
2.65
189.81%
10.70
0.00
0.00
9.04
0.00
0.00
6.79
0.00
0.00
Tax
0.02
0.19
-89.47%
0.21
0.00
0.00
0.13
0.00
0.00
-0.19
0.00
-
PAT
7.66
2.46
211.38%
10.49
0.00
0.00
8.91
0.00
0.00
6.97
0.00
0.00
PATM
3.77%
1.50%
4.80%
0.00%
4.20%
0.00%
4.01%
0.00%
EPS
0.17
0.05
240.00%
0.23
0.00
0.00
0.20
0.00
0.00
0.16
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
807.80
768.54
606.51
595.47
485.08
400.64
366.85
325.92
289.34
228.30
211.86
Net Sales Growth
393.37%
26.72%
1.85%
22.76%
21.08%
9.21%
12.56%
12.64%
26.74%
7.76%
 
Cost Of Goods Sold
525.84
479.12
361.28
358.35
293.33
238.62
209.04
193.53
178.07
142.68
127.05
Gross Profit
281.96
289.42
245.23
237.12
191.76
162.02
157.81
132.39
111.27
85.62
84.80
GP Margin
34.90%
37.66%
40.43%
39.82%
39.53%
40.44%
43.02%
40.62%
38.46%
37.50%
40.03%
Total Expenditure
733.12
701.02
541.78
534.09
423.52
352.41
317.95
294.97
270.11
222.53
200.23
Power & Fuel Cost
-
13.18
11.08
9.84
7.64
7.41
8.42
8.96
9.82
7.69
6.01
% Of Sales
-
1.71%
1.83%
1.65%
1.57%
1.85%
2.30%
2.75%
3.39%
3.37%
2.84%
Employee Cost
-
95.36
76.53
69.69
58.29
48.79
45.08
39.17
36.05
30.52
23.48
% Of Sales
-
12.41%
12.62%
11.70%
12.02%
12.18%
12.29%
12.02%
12.46%
13.37%
11.08%
Manufacturing Exp.
-
31.28
16.21
22.36
13.33
12.68
12.23
11.33
10.20
11.40
9.19
% Of Sales
-
4.07%
2.67%
3.76%
2.75%
3.16%
3.33%
3.48%
3.53%
4.99%
4.34%
General & Admin Exp.
-
36.14
28.52
18.11
18.14
15.89
16.62
13.86
14.37
12.72
13.24
% Of Sales
-
4.70%
4.70%
3.04%
3.74%
3.97%
4.53%
4.25%
4.97%
5.57%
6.25%
Selling & Distn. Exp.
-
32.73
30.04
25.79
23.45
21.40
19.55
20.40
15.85
11.26
18.13
% Of Sales
-
4.26%
4.95%
4.33%
4.83%
5.34%
5.33%
6.26%
5.48%
4.93%
8.56%
Miscellaneous Exp.
-
13.20
18.11
29.95
9.35
7.61
7.01
7.72
5.75
6.26
18.13
% Of Sales
-
1.72%
2.99%
5.03%
1.93%
1.90%
1.91%
2.37%
1.99%
2.74%
1.47%
EBITDA
74.67
67.52
64.73
61.38
61.56
48.23
48.90
30.95
19.23
5.77
11.63
EBITDA Margin
9.24%
8.79%
10.67%
10.31%
12.69%
12.04%
13.33%
9.50%
6.65%
2.53%
5.49%
Other Income
3.87
3.67
3.72
3.72
1.20
1.37
1.22
2.87
1.18
1.04
0.33
Interest
2.11
2.11
4.36
7.56
10.50
8.66
9.92
11.63
7.96
6.27
4.03
Depreciation
42.24
39.90
34.32
33.90
35.20
38.67
45.84
45.80
48.06
48.16
48.02
PBT
34.21
29.18
29.77
23.63
17.06
2.28
-5.64
-23.61
-35.61
-47.62
-40.10
Tax
0.17
0.34
0.00
0.00
-0.13
0.14
0.01
-0.01
0.06
-0.69
0.03
Tax Rate
0.50%
1.17%
0.00%
0.00%
-1.03%
6.14%
-0.36%
0.05%
-0.25%
1.45%
-0.48%
PAT
34.03
28.85
29.59
23.63
12.80
2.14
-2.77
-20.52
-23.65
-46.93
-6.22
PAT before Minority Interest
34.04
28.84
29.77
23.63
12.80
2.14
-2.75
-20.52
-23.63
-46.93
-6.27
Minority Interest
0.01
0.01
-0.18
0.00
0.00
0.00
-0.02
0.00
-0.02
0.00
0.05
PAT Margin
4.21%
3.75%
4.88%
3.97%
2.64%
0.53%
-0.76%
-6.30%
-8.17%
-20.56%
-2.94%
PAT Growth
1,283.33%
-2.50%
25.22%
84.61%
498.13%
-
-
-
-
-
 
Unadjusted EPS
0.76
0.64
0.66
0.53
0.28
0.04
-0.07
-0.45
-0.54
-1.04
-0.15

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
253.09
225.94
196.26
300.28
287.48
297.11
299.88
320.40
344.05
390.99
Share Capital
89.96
89.96
89.96
209.61
209.61
209.61
209.61
209.61
209.61
209.61
Total Reserves
163.13
135.98
106.30
90.67
77.87
87.50
90.27
110.79
134.44
181.38
Non-Current Liabilities
23.38
20.20
17.80
57.47
74.00
84.65
103.91
122.05
135.01
139.74
Secured Loans
1.83
2.95
1.38
43.41
62.27
74.78
94.65
98.85
114.37
128.45
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
15.04
14.32
11.29
Long Term Provisions
19.01
14.42
13.59
11.34
9.22
7.82
7.17
5.73
3.90
0.00
Current Liabilities
339.17
340.12
324.86
166.56
127.92
108.14
102.73
104.95
102.78
85.24
Trade Payables
168.15
174.88
124.88
115.33
84.96
68.60
56.81
64.98
59.79
82.18
Other Current Liabilities
160.64
163.90
198.65
47.04
39.87
37.58
45.22
38.96
41.11
0.00
Short Term Borrowings
8.99
0.00
0.00
0.00
2.23
1.19
0.00
0.00
0.00
0.00
Short Term Provisions
1.39
1.33
1.33
4.19
0.86
0.77
0.70
1.01
1.88
3.06
Total Liabilities
615.18
585.81
538.29
523.68
489.00
489.50
506.09
546.98
581.40
615.53
Net Block
236.21
264.29
271.80
296.72
322.48
368.08
409.46
451.86
496.02
540.18
Gross Block
887.76
997.60
1,026.96
1,018.43
1,009.35
1,004.61
1,000.44
997.38
997.96
995.54
Accumulated Depreciation
651.55
733.31
755.15
721.72
686.87
636.53
590.98
545.52
501.94
455.35
Non Current Assets
315.71
338.68
346.34
366.53
374.42
393.18
415.00
457.37
501.38
544.15
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
3.87
3.87
3.97
3.97
Long Term Loans & Adv.
79.22
74.12
73.69
69.82
51.94
25.10
1.67
1.64
1.39
0.00
Other Non Current Assets
0.28
0.27
0.85
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
299.47
247.13
191.95
157.15
114.58
96.32
91.09
89.61
80.02
69.96
Current Investments
0.02
0.22
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
94.20
76.89
64.66
42.14
37.11
33.30
37.05
38.66
34.70
31.68
Sundry Debtors
133.75
121.85
92.95
87.94
56.14
42.67
39.11
35.15
29.64
23.83
Cash & Bank
32.21
5.95
7.59
4.36
8.85
9.11
5.53
4.51
2.58
1.10
Other Current Assets
39.29
5.62
4.71
5.94
12.48
11.24
9.40
11.29
13.10
13.34
Short Term Loans & Adv.
31.43
36.61
22.03
16.77
9.34
8.23
6.23
9.60
10.30
11.19
Net Current Assets
-39.70
-92.99
-132.92
-9.41
-13.34
-11.82
-11.64
-15.34
-22.76
-15.28
Total Assets
615.18
585.81
538.29
523.68
489.00
489.50
506.09
546.98
581.40
615.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
17.37
63.41
40.73
50.07
50.70
33.52
33.64
27.11
11.13
6.67
PBT
29.18
29.86
23.04
17.06
2.28
-5.64
-23.60
-35.61
-47.62
-40.10
Adjustment
40.33
38.55
41.40
45.69
47.32
55.76
56.80
55.99
54.44
51.68
Changes in Working Capital
-51.79
-5.00
-23.72
-8.41
1.23
-19.50
-2.64
-5.25
3.63
-4.50
Cash after chg. in Working capital
17.71
63.41
40.73
54.34
50.83
30.62
30.56
15.13
10.45
7.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.34
0.00
0.00
0.13
-0.13
0.01
0.01
-0.06
0.68
-0.03
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
-4.40
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-13.05
-26.93
-13.60
-27.30
-31.65
-0.80
-2.83
-3.35
-4.05
-4.43
Net Fixed Assets
113.16
31.96
-8.08
-7.02
-4.73
-4.09
-2.87
0.60
-2.41
-4.29
Net Investments
0.20
-0.22
0.00
0.25
0.00
3.87
0.00
0.10
0.00
0.00
Others
-126.41
-58.67
-5.52
-20.53
-26.92
-0.58
0.04
-4.05
-1.64
-0.14
Cash from Financing Activity
-0.44
-37.77
-23.72
-27.26
-19.31
-29.14
-29.79
-21.83
-5.60
-5.72
Net Cash Inflow / Outflow
3.88
-1.29
3.40
-4.49
-0.26
3.58
1.02
1.93
1.48
-3.48
Opening Cash & Equivalents
5.72
7.00
3.60
8.85
9.11
5.53
4.51
2.58
1.10
4.59
Closing Cash & Equivalent
9.60
5.72
7.00
4.36
8.85
9.11
5.53
4.51
2.58
1.10

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
5.63
5.02
4.36
4.02
3.73
3.95
4.01
4.46
4.99
6.00
ROA
4.80%
5.30%
4.45%
2.53%
0.44%
-0.55%
-3.90%
-4.19%
-7.84%
-0.99%
ROE
12.04%
14.10%
12.54%
7.35%
1.24%
-1.54%
-10.77%
-11.12%
-18.99%
-2.86%
ROCE
12.38%
14.05%
10.18%
6.29%
2.90%
1.80%
-2.09%
-3.40%
-8.22%
-0.40%
Fixed Asset Turnover
0.82
0.60
0.58
0.49
0.41
0.37
0.33
0.29
0.23
0.21
Receivable days
60.70
64.63
55.44
53.22
44.17
40.16
40.83
40.35
42.17
38.81
Inventory Days
40.63
42.59
32.73
29.27
31.48
34.55
41.63
45.68
52.36
46.50
Payable days
88.85
103.38
82.97
83.88
76.01
67.69
69.30
75.59
101.91
124.72
Cash Conversion Cycle
12.48
3.85
5.20
-1.39
-0.36
7.02
13.16
10.44
-7.39
-39.41
Total Debt/Equity
0.05
0.06
0.25
0.22
0.28
0.30
0.37
0.38
0.39
0.36
Interest Cover
14.83
7.83
4.13
2.21
1.26
0.72
-0.77
-1.96
-6.59
-0.55

News Update:


  • Morepen Laboratories sells 36.7 million Blood Glucose testing strips in Q1FY20
    14th Aug 2019, 10:10 AM

    The company has achieved a milestone of selling 325 million glucose testing strips till the end of the quarter under consideration in the current fiscal

    Read More
  • Morepen Laboratories - Quarterly Results
    13th Aug 2019, 16:39 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.